BG103402A - Подобрения на, или свързани с контрастните средства - Google Patents

Подобрения на, или свързани с контрастните средства Download PDF

Info

Publication number
BG103402A
BG103402A BG103402A BG10340299A BG103402A BG 103402 A BG103402 A BG 103402A BG 103402 A BG103402 A BG 103402A BG 10340299 A BG10340299 A BG 10340299A BG 103402 A BG103402 A BG 103402A
Authority
BG
Bulgaria
Prior art keywords
emulsion
dispersion
gas
preparation according
combination preparation
Prior art date
Application number
BG103402A
Other languages
Bulgarian (bg)
English (en)
Inventor
Jonny Ostensen
Morten Eriksen
Sigmund Frigstad
Pal Rongved
Original Assignee
Amersham Health As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9621884.7A external-priority patent/GB9621884D0/en
Priority claimed from GBGB9708239.0A external-priority patent/GB9708239D0/en
Application filed by Amersham Health As filed Critical Amersham Health As
Publication of BG103402A publication Critical patent/BG103402A/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/927—Diagnostic contrast agent
    • Y10S977/928—X-ray agent
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/927—Diagnostic contrast agent
    • Y10S977/929—Ultrasound contrast agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Acoustics & Sound (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BG103402A 1996-10-21 1999-05-14 Подобрения на, или свързани с контрастните средства BG103402A (bg)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9621884.7A GB9621884D0 (en) 1996-10-21 1996-10-21 Improvements in or relating to contrast agents
GBGB9708239.0A GB9708239D0 (en) 1997-04-23 1997-04-23 Improvements in or relating to contrast agents
PCT/GB1997/002898 WO1998017324A2 (fr) 1996-10-21 1997-10-21 Ameliorations apportees ou relatives a des agents de contraste

Publications (1)

Publication Number Publication Date
BG103402A true BG103402A (bg) 2000-01-31

Family

ID=26310262

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103402A BG103402A (bg) 1996-10-21 1999-05-14 Подобрения на, или свързани с контрастните средства

Country Status (26)

Country Link
US (3) US6375931B2 (fr)
EP (2) EP1007100B1 (fr)
JP (1) JP2001502349A (fr)
KR (1) KR20000052652A (fr)
CN (1) CN1106859C (fr)
AP (1) AP885A (fr)
AT (2) ATE238073T1 (fr)
AU (1) AU745047B2 (fr)
BG (1) BG103402A (fr)
BR (1) BR9712370A (fr)
CA (1) CA2269319C (fr)
CZ (1) CZ140999A3 (fr)
DE (2) DE69721331T2 (fr)
EE (1) EE03749B1 (fr)
ES (1) ES2197336T3 (fr)
HU (1) HU224218B1 (fr)
ID (1) ID21681A (fr)
IL (1) IL129423A (fr)
MX (1) MXPA99003664A (fr)
NO (1) NO991869L (fr)
NZ (1) NZ335265A (fr)
PL (1) PL332820A1 (fr)
RU (1) RU2204415C2 (fr)
SK (1) SK283210B6 (fr)
TR (1) TR199901544T2 (fr)
WO (1) WO1998017324A2 (fr)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6774278B1 (en) 1995-06-07 2004-08-10 Cook Incorporated Coated implantable medical device
CA2248158A1 (fr) * 1996-03-12 1997-09-18 The Board Of Regents Of The University Of Nebraska Compositions d'apport de medicaments cible sur un site specifique et procede d'utilisation
US5846517A (en) * 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator
WO1998010798A1 (fr) * 1996-09-11 1998-03-19 Imarx Pharmaceutical Corp. Procedes ameliores d'imagerie diagnostique utilisant un agent de contraste et un vasodilatateur
SK283210B6 (sk) * 1996-10-21 2003-03-04 Amersham Health As Kombinovaný prípravok na simultánne, oddelené alebo sekvenčné použitie ako kontrastné činidlo pri ultrazvukovom zobrazení
GB9708246D0 (en) 1997-04-24 1997-06-18 Nycomed Imaging As Improvements in or relating to ultrasound imaging
GB9717588D0 (en) * 1997-08-19 1997-10-22 Nycomed Imaging As Improvements in or relating to contrast agents
EP1024837A1 (fr) * 1997-10-21 2000-08-09 Nycomed Imaging As Imagerie ultrasonique avec agent de contraste cible sur le systeme microvasculaire et medicament vasodilatateur
US20010003580A1 (en) 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
DE19805012A1 (de) * 1998-02-07 1999-08-12 Thomas Gieselmann Kontrastmittel zur Verwendung als Diagnostikum bei bildgebenden Verfahren sowie seine Herstellung
US20040170564A1 (en) * 1998-04-22 2004-09-02 Roald Skurtveit Ultrasound contrast agent dispersions comprising gas and destabilising agent
GB9808582D0 (en) * 1998-04-22 1998-06-24 Nycomed Imaging As Improvements in or relating to contrast agents
GB9808599D0 (en) * 1998-04-22 1998-06-24 Nycomed Imaging As Improvements in or realting to contrast agents
GB9808581D0 (en) * 1998-04-22 1998-06-24 Nycomed Imaging As Improvements in or relating to contrast agents
GB9813568D0 (en) * 1998-06-23 1998-08-19 Nycomed Imaging As Improvements in or relating to cardiac imaging
US6984373B2 (en) 2000-12-23 2006-01-10 Dyax Corp. Fibrin binding moieties useful as imaging agents
NO20010234D0 (no) * 2001-01-12 2001-01-12 Nycomed Imaging As Perfusjon avbildningsbilde
US7179449B2 (en) * 2001-01-30 2007-02-20 Barnes-Jewish Hospital Enhanced ultrasound detection with temperature-dependent contrast agents
DE10115740A1 (de) * 2001-03-26 2002-10-02 Ulrich Speck Zubereitung für die Restenoseprophylaxe
US20080193490A1 (en) * 2002-02-14 2008-08-14 Andreas Hirsch Use of Carbon Nanotube for Drug Delivery
US20040166152A1 (en) * 2002-02-14 2004-08-26 Andreas Hirsch Use of buckysome or carbon nanotube for drug delivery
US7794693B2 (en) 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
US8623822B2 (en) 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
WO2004065621A1 (fr) 2002-03-01 2004-08-05 Dyax Corp. Peptides de liaison kdr et vegf/kdr et leur utilisation a des fins diagnostiques et therapeutiques
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
EP2301587B1 (fr) 2002-03-01 2014-06-25 Dyax Corp. Peptides de liaison KDR et VEGF/KDR et leur utilisation pour le diagnostic et la thérapie
US20090060992A1 (en) * 2002-05-08 2009-03-05 University Of Central Florida Research Foundation, Inc., Preparation of magneto-vesicles with DOPE/DDAB layers
WO2003097125A2 (fr) * 2002-05-17 2003-11-27 Case Western Reserve University Technique de double contraste pour interventions vasculaires guidees par irm
WO2004026345A1 (fr) * 2002-09-19 2004-04-01 New York University Regulation de la bioactivite du monoxyde d'azote par des perfluocarbones
DE10244847A1 (de) 2002-09-20 2004-04-01 Ulrich Prof. Dr. Speck Medizinische Vorrichtung zur Arzneimittelabgabe
EP1593091B1 (fr) * 2003-01-25 2013-07-17 Seno Medical Instruments, Inc. Méthode d'imagerie optoacoustique à contraste élevé utilisant des nanoparticules non-sphériques
US20040146461A1 (en) * 2003-01-29 2004-07-29 Vincenzo Giuliano Oral contrast media composition for computerized axial tomographic examinations and method
US7378081B2 (en) 2003-01-29 2008-05-27 Vincon Research Enterprises, Llc Composition and method for direct visualization of the human appendix
WO2004067015A1 (fr) * 2003-01-31 2004-08-12 Otsuka Pharmaceutical Factory, Inc. Agent auxiliaire destine a etre utilise dans le traitement de cancer par chauffage dielectrique et procede de traitement du cancer
DE602004029010D1 (de) * 2003-02-04 2010-10-21 Bracco Suisse Sa Ultraschall kontrastmittel und verfahren zur erstellung
US20070128117A1 (en) * 2003-02-04 2007-06-07 Bracco International B.V. Ultrasound contrast agents and process for the preparation thereof
DK2284180T3 (en) 2003-03-03 2015-12-21 Dyax Corp Uses of peptides that specifically bind to the HGF receptor (cMET)
US20040258760A1 (en) * 2003-03-20 2004-12-23 Wheatley Margaret A. Isolated nanocapsule populations and surfactant-stabilized microcapsules and nanocapsules for diagnostic imaging and drug delivery and methods for their production
US20080299047A1 (en) * 2003-07-31 2008-12-04 National Cheng Kung University Method for preparation of water-soluble and dispersed iron oxide nanoparticles and application thereof
SE526838C2 (sv) * 2003-11-27 2005-11-08 Xcounter Ab Undersökningsmetod och anordning för detektion av joniserande strålning
US9750821B2 (en) * 2003-12-22 2017-09-05 Bracco Suisse S.A. Gas-filled microvesicle assembly for contrast imaging
CA2562606A1 (fr) * 2004-04-13 2005-10-27 Cambridge Biostability Limited Liquides contenant des particules de verre en suspension
US8012457B2 (en) * 2004-06-04 2011-09-06 Acusphere, Inc. Ultrasound contrast agent dosage formulation
EP1784228B1 (fr) * 2004-08-18 2016-10-05 Bracco Suisse SA Composition à base de microvésicules remplis de gaz pour l'imagerie de contraste
US8034222B2 (en) * 2004-10-26 2011-10-11 The Regents Of The University Of California Conducting polymer nanowire sensors
US8153435B1 (en) 2005-03-30 2012-04-10 Tracer Detection Technology Corp. Methods and articles for identifying objects using encapsulated perfluorocarbon tracers
US20070167861A1 (en) * 2005-11-29 2007-07-19 Lopez George A Cardiac output measurement devices and methods
CA2631716C (fr) 2005-12-09 2013-11-26 Bracco International B.V. Conjugues vecteur de ciblage-phospholipides
EP1989285A2 (fr) * 2006-02-28 2008-11-12 E.I. Du Pont De Nemours And Company Compositions azéotropiques comprenant des composés fluorés pour des applications de nettoyage
CN100400105C (zh) * 2006-05-11 2008-07-09 上海交通大学 水性基质的消化道ct阴性造影剂及其制备方法
JP4279328B2 (ja) * 2007-05-07 2009-06-17 株式会社日立製作所 超音波撮像システム
KR100957560B1 (ko) * 2007-10-18 2010-05-11 한국생명공학연구원 양자점 나노입자를 함유한 퍼플루오르카본 나노에멀젼 및그 제조방법
GB0811856D0 (en) * 2008-06-27 2008-07-30 Ucl Business Plc Magnetic microbubbles, methods of preparing them and their uses
US8908939B2 (en) * 2008-09-30 2014-12-09 Koninklijke Philips N.V. Perfusion imaging
US9072490B2 (en) * 2010-12-20 2015-07-07 Toshiba Medical Systems Corporation Image processing apparatus and image processing method
ITRM20110022A1 (it) * 2011-01-21 2012-07-22 Gaio Paradossi Metodo per la preparazione di microbolle comprendenti un agente di contrasto
RU2454174C2 (ru) * 2011-03-16 2012-06-27 Федеральное государственное учреждение "Московский научно-исследовательский онкологический институт им. П.А. Герцена" Министерства здравоохранения и социального развития Российской Федерации (ФГУ "МНИОИ им. П.А. Герцена" Минздравсоцразвития России) Способ диагностики опухолей шейки матки
RU2453270C1 (ru) * 2011-03-31 2012-06-20 Федеральное государственное учреждение "Московский научно-исследовательский онкологический институт им. П.А. Герцена Министерства здравоохранения и социального развития Российской Федерации" (ФГУ "МНИОИ им. П.А. Герцена" Минздравсоцразвития России) Способ исследования терминального отдела толстой кишки
RU2485976C2 (ru) * 2011-05-17 2013-06-27 Государственное образовательное учреждение высшего профессионального образования "Сибирский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации (ГОУ ВПО СибГМУ Минздравсоцразвития России) Контрастное средство для ультразвуковой визуализации
IN2014DN09192A (fr) * 2012-04-30 2015-07-10 Ge Healthcare As
EP2864033B1 (fr) * 2012-06-26 2016-04-06 GE Healthcare AS Préparation de composition comprenant des microbulles de gaz
CN103100093B (zh) * 2013-01-23 2015-05-06 中山大学附属第三医院 一种负载小干扰rna的纳米级脂质微泡超声造影剂及制备方法
DK3049117T3 (da) 2013-09-27 2022-10-31 Exact Therapeutics As Ultralydsmedieret afgivelse af lægemidler
BR112017013787A2 (pt) 2014-12-31 2018-03-13 Lantheus Medical Imaging, Inc. Composições de microesfera de gás lipídio- encapsulado e métodos relacionados
CA3022698A1 (fr) 2016-05-04 2017-11-09 Lantheus Medical Imaging, Inc. Methodes et dispositifs de preparation d'agents de contraste ultrasonores
US9789210B1 (en) 2016-07-06 2017-10-17 Lantheus Medical Imaging, Inc. Methods for making ultrasound contrast agents
GB201821049D0 (en) * 2018-12-21 2019-02-06 Ge Healthcare As Ultrasound contrast agent and methods for use therof
US11642172B2 (en) * 2019-03-05 2023-05-09 Biosense Webster (Israel) Ltd. Showing catheter in brain
US12005130B2 (en) 2019-10-16 2024-06-11 Agitated Solutions Inc. Generating microbubbles for bubble studies
US11191888B1 (en) 2020-05-18 2021-12-07 Agitated Solutions Inc. Syringe-based microbubble generator
RU2744825C1 (ru) * 2020-06-03 2021-03-16 Федеральное государственное бюджетное образовательное учреждение высшего образования "Смоленский государственный медицинский университет" министерства здравоохранения Российской Федерации Способ определения времени течения артериальной фазы эхоконтрастирования печени, почек и селезенки

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5070877A (en) * 1988-08-11 1991-12-10 Medco Research, Inc. Novel method of myocardial imaging
US5585112A (en) * 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
US5773024A (en) * 1989-12-22 1998-06-30 Imarx Pharmaceutical Corp. Container with multi-phase composition for use in diagnostic and therapeutic applications
US5117830A (en) * 1990-11-08 1992-06-02 Whitby Research, Inc. Method of determining viability of tissue
EP0680341B1 (fr) * 1993-01-25 2001-05-09 Sonus Pharmaceuticals, Inc. Colloides a decalage de phase utiles comme agents de contraste ultrasonores
US5362478A (en) * 1993-03-26 1994-11-08 Vivorx Pharmaceuticals, Inc. Magnetic resonance imaging with fluorocarbons encapsulated in a cross-linked polymeric shell
US5716597A (en) * 1993-06-04 1998-02-10 Molecular Biosystems, Inc. Emulsions as contrast agents and method of use
US5798091A (en) * 1993-07-30 1998-08-25 Alliance Pharmaceutical Corp. Stabilized gas emulsion containing phospholipid for ultrasound contrast enhancement
CA2164813C (fr) * 1993-07-30 2009-11-24 Ernest G. Schutt Composes de micro-bulles stabilisees servant d'agents contrastants
DE4406474A1 (de) * 1994-02-23 1995-08-24 Schering Ag Gas enthaltende Mikropartikel, diese enthaltende Mittel, deren Verwendung in der Ultraschalldiagnostik, sowie Verfahren zur Herstellung der Partikel und Mittel
GB9423419D0 (en) * 1994-11-19 1995-01-11 Andaris Ltd Preparation of hollow microcapsules
US5560364A (en) * 1995-05-12 1996-10-01 The Board Of Regents Of The University Of Nebraska Suspended ultra-sound induced microbubble cavitation imaging
US5804162A (en) * 1995-06-07 1998-09-08 Alliance Pharmaceutical Corp. Gas emulsions stabilized with fluorinated ethers having low Ostwald coefficients
US5846517A (en) * 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator
SK283210B6 (sk) * 1996-10-21 2003-03-04 Amersham Health As Kombinovaný prípravok na simultánne, oddelené alebo sekvenčné použitie ako kontrastné činidlo pri ultrazvukovom zobrazení
US6054118A (en) * 1997-01-22 2000-04-25 Nycomed Imaging As Contrast agents comprising two types of gas-containing microparticles

Also Published As

Publication number Publication date
US20010002993A1 (en) 2001-06-07
EE03749B1 (et) 2002-06-17
SK52099A3 (en) 2000-01-18
KR20000052652A (ko) 2000-08-25
BR9712370A (pt) 1999-08-31
EP1264604A2 (fr) 2002-12-11
US20040141921A1 (en) 2004-07-22
IL129423A0 (en) 2000-02-17
IL129423A (en) 2003-01-12
CA2269319A1 (fr) 1998-04-30
US6375931B2 (en) 2002-04-23
DE69721331T2 (de) 2004-05-06
EP1264604B1 (fr) 2007-12-19
EE9900158A (et) 1999-12-15
AP9901511A0 (en) 1999-06-30
EP1264604A3 (fr) 2004-03-10
ATE238073T1 (de) 2003-05-15
WO1998017324A2 (fr) 1998-04-30
AU4714797A (en) 1998-05-15
RU2204415C2 (ru) 2003-05-20
NZ335265A (en) 2000-07-28
ATE381353T1 (de) 2008-01-15
DE69738406D1 (de) 2008-01-31
AU745047B2 (en) 2002-03-07
SK283210B6 (sk) 2003-03-04
NO991869D0 (no) 1999-04-19
EP1007100A2 (fr) 2000-06-14
AP885A (en) 2000-11-03
CN1106859C (zh) 2003-04-30
JP2001502349A (ja) 2001-02-20
DE69738406T2 (de) 2008-12-04
EP1007100B1 (fr) 2003-04-23
NO991869L (no) 1999-06-02
ID21681A (id) 1999-07-08
US20050118104A1 (en) 2005-06-02
DE69721331D1 (de) 2003-05-28
HUP0000282A3 (en) 2001-09-28
MXPA99003664A (es) 2002-06-11
HU224218B1 (hu) 2005-06-28
US6783752B2 (en) 2004-08-31
CN1238699A (zh) 1999-12-15
CZ140999A3 (cs) 1999-09-15
PL332820A1 (en) 1999-10-11
HUP0000282A2 (hu) 2000-05-28
TR199901544T2 (xx) 1999-09-21
ES2197336T3 (es) 2004-01-01
CA2269319C (fr) 2008-03-18
WO1998017324A3 (fr) 1998-06-25

Similar Documents

Publication Publication Date Title
BG103402A (bg) Подобрения на, или свързани с контрастните средства
US7179449B2 (en) Enhanced ultrasound detection with temperature-dependent contrast agents
EP1073473B1 (fr) Ameliorations apportees a des agents de contraste ou en rapport avec ces agents
JP5513708B2 (ja) 造影イメージング用の気体封入マイクロベシクル・アセンブリー
US5976501A (en) Use of pressure resistant protein microspheres encapsulating gases as ultrasonic imaging agents for vascular perfusion
JP2001514615A (ja) 生物活性剤の送達方法
US20040131547A1 (en) Contrast agents
JP2002512208A (ja) 造影剤における改良または造影剤に関する改良
DE69921317T2 (de) Gas und destabilisierungsmittel enthaltende ultraschallkontrastmitteldispersionen
US20040170564A1 (en) Ultrasound contrast agent dispersions comprising gas and destabilising agent
MXPA00010301A (en) Improvements in or relating to contrast agents
CZ20003896A3 (cs) Kombinovaný prostředek